Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272231 · ClinicalTrials.gov registry record
Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 42
- Enrollment target
NCT02272231: Completed study, sponsored by University of Alabama at Birmingham.
NCT02272231 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272231 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The objectives of this study are to: (1) use cultivation-independent molecular methods to determine the sequence of microbiological events culminating in bacterial vaginosis (BV) among sexually active African American women who have sex with women (AAWSW) and (2) determine if specific Gardnerella vaginalis oligotypes are associated with the development of BV among sexually active AAWSW.
Primary Outcome
Based on 3 consecutive days of Nugent score readings of 7-10 (vaginal Gram stain result)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-01 |
What the finished NCT02272231 record still lists
NCT02272231 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02272231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02272231 about?
NCT02272231 is a clinical study titled "Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women". The objectives of this study are to: (1) use cultivation-independent molecular methods to determine the sequence of microbiological events culminating in bacterial vaginosis (BV) among sexually active African American women who have sex with women (AAWSW) and (2) determine if specific Gardnerella va...
What is the current status of trial NCT02272231?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2014-09. Estimated completion is 2019-01.
Who is sponsoring clinical trial NCT02272231?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia